We previously evaluated the renal excretion mechanism of quinidine, which is a tertiary amine compound, using porcine kidney epithelial LLC-PK 1 cells and P-glycoprotein (P-gp)-expressed LLC-GA5-COL150 cells.
Procainamide, another tertiary amine compound with a pK a value of 9.23, is classified as a type IA antiarrhythmic drug that works by decreasing conduction velocity, and prolonging tissue refractoriness.
3) More than 80% of orally administered procainamide is absorbed from the intestine in humans. 4) The Kp (octanol/buffer at pH 7.4) value of procainamide is about 0.1, and approximately half of the dose is excreted in the urine as unchanged drug. [3] [4] [5] [6] However, the mechanisms responsible for the membrane transport of procainamide in intestinal and renal epithelial cells are still unclear.
In the present study, the transport characteristics of procainamide in LLC-PK 1 cells were compared with those of quinidine. In addition, we evaluated whether the transport system for quinidine is present in another intestinal cell line, LS180, as well as Caco-2. We also investigated whether the transport system of procainamide in LS180 cells is the same as that of quinidine. (1. 96 GBq/mmol) was purchased from Moravek Biochemicals (Brea, CA, U.S.A.). TEA chloride and procainamide hydrochloride were obtained from Nacalai Tesque Inc. (Kyoto, Japan). Quinidine hydrochloride monohydrate was purchased from Sigma Aldrich (St. Louis, MO, U.S.A.). All other chemicals were of the highest purity available.
MATERIALS AND METHODS

Materials
Cell Culture and Preparation of Monolayers LLC-PK 1 cells at passage 197 and LS180 cells at passage 38 were obtained from the American Type Culture Collection (Manassas, VA, U.S.A.). These cells were maintained by serial passage in plastic dishes with Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum (Biowest Inc., Nuaille, France) in an atmosphere of 5% CO 2 -95% air at 37°C.
LLC-PK 1 cells were seeded at a density of 5ϫ10 5 cells/ cm 2 on a 1.12 cm 2 porous membrane (3 mm pore size) in a polyester membrane Transwell ® -Clear insert (Costar, Cambridge, MA, U.S.A.) to evaluate the transcellular transport of cationic drugs. The seeded cells were maintained for 6 d to prepare differentiated cell monolayers. The maturity of the monolayer was judged by transepithelial electrical resistance (TEER). TEER was measured using a Millicell-ERS resistance system (Millipore, Bedford, MA, U.S.A.). LLC-PK 1 cell monolayers whose TEER was above 60 W · cm 2 were used to assess the transcellular transport of cationic drugs. ]procainamide in LLC-PK 1 cell monolayers prepared on a porous membrane was examined as described previously. 1, 7) In brief, the monolayer was pre-incubated for 30 min at 37°C with culture medium (pH 6.3) containing 10 mM unlabeled drug to equilibrate the drug concentration. After the equilibration period, the radio-labeled drug (0.33 mCi/ml) was applied to the apical chamber (0.75 ml) to examine apical-to-basolateral transcellular transport. 1, 7, 8) A volume (50 ml) of medium in the basolateral chamber (1.5 ml) was then collected 30, 60, and 90 min after the radio-labeled drug was applied. Cells on the porous membrane were collected following the last collection of medium. Radioactivity in the medium and cells was determined using a liquid scintillation counter, and normalized against the initially applied doses. The time course of the transport of cationic drugs in the opposite (basolateral-to-apical) direction was examined in a similar manner.
The ]procainamide were analyzed in a model-dependent manner using NONMEM software running on a mainframe UNIX machine at the Kyoto University Data Processing Center, as described previously. 1, 7, 8) When transcellular drug transport is examined under the condition where the unlabeled drug concentration in the monolayer is equilibrated with that of the incubation medium in the apical and basolateral chambers, transport data for a small amount of radiolabeled drug can be analyzed using the linear pharmacokinetic model. That is, the following mass balance equations were prepared for pharmacokinetic analysis: (1) (2) (3) where X A , X B , and X C are the amounts of radio-labeled drugs in the apical chamber, basolateral chamber, and monolayer determined at time t, respectively. V A and V B indicate the volume of the apical chamber (0.75 ml) and the basolateral chamber (1.5 ml), respectively. V C indicates the cell volume of cell monolayers obtained from sulfanilamide accumulation experiments, as described previously (1.12 ml/cm 2 ϫ 1.12 cm 2 ϭ1.25 ml).
1) The influx and efflux clearance of cationic drugs at the apical membrane of cells was designated as CL A→C and CL C→A , respectively. The influx and efflux clearance of cationic drugs at the basolateral membrane of cells was designated as CL B→C and CL C→B , respectively. Paracellular transport clearance (CL A↔B ) was estimated by analyzing the transport profile of mannitol using the following mass balance equations: ( , and the pH of the medium was adjusted with a solution of NaOH. In order to evaluate the effect of the extracellular pH on the cellular uptake of cationic drugs, HEPES (neutral pH) was replaced with 2-(N-morpholino) ethanesulfonic acid (pH 5.5). The cells were first pre-incubated for 10 min at 37 or 4°C with 2 ml incubation medium containing 100 mM unlabeled drug to equilibrate the drug concentration, followed by incubation for 5 min with 1 ml fresh incubation medium. The incubation medium was replaced with 1 ml fresh incubation medium containing radiolabeled drug (0.2 mCi/ml). After the cells were incubated with radio-labeled drug for another 5-30 min at 37 or 4°C, they were immediately washed with ice-cold phosphate buffer and collected. Radioactivity in the cells was determined as described above. Radio-labeled mannitol was used to estimate the extracellular trapping of cationic drugs. [8] [9] [10] [11] The cellular uptake of [ 3 H]quinidine and [ 14 C]procainamide was analyzed in a model-dependent manner using NONMEM software, as described previously. 9, 10) The following mass balance equations were prepared for the pharmacokinetic analysis: (6) (7) where X M and X C are the amount of radio-labeled drugs in the incubation medium and the cells determined at time t, respectively. V M indicates the volume of incubation medium (1 ml). V C indicates the cell volume (2.62 ml/cm 2 ϫ3.8 cm 2 ϭ 9.96 ml), measured with sulfanilamide, as described previously.
8) The influx and efflux clearances of cationic drugs were designated as CL M→C and CL C→M , respectively.
In order to evaluate the effect of extracellular Na ϩ on the cellular uptake of [ 3 H]quinidine and [
NaCl in incubation medium was replaced with N-methyl-D-glucamine hydrochloride, and the pH of the medium was adjusted to 7.4 by the addition of KOH. The effect of various cationic drugs on the uptake of [ 3 H]quinidine and [ 14 C]procainamide in LS180 cells on plastic dishes of a multiwell plate was evaluated at 37°C. That is, the cells were first preincubated for 10 min with 2 ml incubation medium, followed by 5 min incubation with 1 ml fresh incubation medium supplemented with 1 mM various cationic drugs. The incubation medium was replaced with 1 ml incubation medium containing radio-labeled drug (0.2 mCi/ml). After the cells were incubated with radio-labeled drug for 5 min, the amount of radio-labeled drug in the cells was determined as described above.
Statistical Analysis Values are expressed as the meanϮ S.E. In all figures, when error bars are not shown, they are smaller than the symbol. Multiple comparisons were performed using Scheffé's test following one-way ANOVA provided that the variances of groups were similar. If this was not the case, Scheffé-type test was applied following Kruskal-Wallis analysis. The statistical significance of differences between two groups was tested using Student's t-test provided that the variances of the groups were similar. If this was not the case, the Mann-Whitney U-test was applied. pϽ0.05 was considered to be statistically significant.
RESULTS
Transcellular Transport and Membrane Transport Characteristics of TEA, Quinidine, and Procainamide in Renal Epithelial LLC-PK 1 Cells Previously, we investigated the transcellular transport of 100 mM and 0.1 mM quinidine in LLC-PK 1 cells, and reported that quinidine is not significantly transported via the transport systems involved in the directional transport of TEA. 1) In the present study, we first evaluated the transcellular transport of 10 mM TEA and quinidine across LLC-PK 1 cell monolayers (Figs. 1A-C) , and performed a pharmacokinetic analysis of the data on the transcellular transport and cellular accumulation of radiolabeled drug using a 3-compartment (apical and basolateral chambers, and cell) model (Table 1 ). The transcellular transport of 10 mM TEA in the basolateral-to-apical direction was much greater than that in the opposite direction (Fig. 1A) . The CL B→C value was greater than the CL A→C value, and the CL C→A value was greater than the CL C→B value (Table 1) . On the other hand, the transcellular transport of 10 mM quinidine in the basolateral-to-apical direction was similar to that in the opposite direction (Fig. 1B) . The CL B→C value of quinidine was similar to the CL A→C value, and the CL C→B value was also similar to the CL C→A value. In addition, the transcellular transport and membrane transport clearance of quinidine were not affected by 1 mM TEA (Fig. 1C) . According to these findings, it was reconfirmed that the transport systems for TEA contribute little to the transcellular transport of quinidine in renal LLC-PK 1 cells.
We next evaluated the transcellular transport and membrane transport clearance of 10 mM procainamide in LLC-PK 1 cell monolayers (Figs. 1D, E) . Procainamide was transported directionally from the basolateral side to the apical side (Fig. 1D) . The estimated CL C→A value was greater than any other clearance values (Table 1) . Moreover, directional transport of procainamide was diminished in the presence of 1 mM TEA (Fig. 1E) . The CL B→C and CL C→A values were decreased to 82.7% and 51.4% of the control values, respec- tively, by 1 mM TEA (Table 1 ). These findings indicated that the transport systems for TEA significantly contribute to the transcellular transport of procainamide in renal LLC-PK 1 cells.
Cellular Uptake of Quinidine and Procainamide in Intestinal Epithelial LS180 Cells
We have previously reported that a cation transport system is involved in the apical uptake of 100 mM quinidine in human intestinal epithelial Caco-2 cells. 2, 7) In the present study, we investigated whether the cation transport system for quinidine is present in another human intestinal epithelial cell line, LS180. Figure  2A shows the time course of the uptake of 100 mM quinidine at 37°C and 4°C in LS180 cells grown on plastic dishes. The cellular uptake of quinidine was temperature-dependent, and reached approximately 10% of the dose for 30 min at 37°C (Fig. 2A) . We performed a pharmacokinetic analysis of the data on the cellular accumulation of quinidine using a 2-compartment (cell and medium) model ( Table 2 ). The CL M→C and CL C→M values of quinidine at 37°C were much greater than those at 4°C (Table 2 ). We next investigated the effect of extracellular Na ϩ and pH on the initial (5-min) uptake of quinidine in LS180 cells (Figs. 3A, 4A ). No marked difference was observed in the cellular uptake of quinidine in the absence of extracellular Na ϩ (Fig. 3A) , whereas the cellular uptake of quinidine was markedly greater at pH 7.5 than at pH 5.5 (Fig. 4A) . We also evaluated the effect of 1 mM various cationic drugs on the cellular uptake of quinidine, which was significantly inhibited by hydrophobic organic cations, but not by typical hydrophilic cations, TEA and choline (Fig.  5A) . The rank order of the inhibitory effects of hydrophobic cationic drugs on the uptake of quinidine was imipramineϾ quinidineϾdiphenhydramineϷpyrilamineϾprocainamide (Fig. 5A) . These findings suggested that quinidine was transported by the cation transport system in intestinal LS180 cells, as well as Caco-2 cells.
To compare the membrane transport characteristics of procainamide with those of quinidine in intestinal epithelial cells, we also evaluated the uptake of 100 mM procainamide using LS180 cells. The cellular uptake of procainamide was temperature-dependent, and reached approximately 4.4% of the dose for 30 min at 37°C (Fig. 2B) . The CL M→C and CL C→M values of procainamide at 37°C were much greater than those at 4°C ( Table 2 ). As shown in Figs. 3B and 4B , 1410 Vol. 33, No. 8
Fig. 2 Time Course of the Uptake of Quinidine and Procainamide in LS180 Cells
(A) 100 mM quinidine, (B) 100 mM procainamide. Circles and triangles represent cellular uptake of drugs at 37°C and 4°C, respectively. Solid lines represent simulation curves obtained by pharmacokinetic analysis of the drug accumulation. Fig. 3 Effect of Extracellular Na + on the Uptake of Quinidine and Procainamide in LS180 Cells (A) 100 mM quinidine, (B) 100 mM procainamide. The cells were incubated with the radio-labeled drug for 5 min. Each column represents the meanϮS.E. for 6 measurements. * p<0.05; significantly different from Na ϩ (ϩ).
Fig. 4 Effect of Extracellular pH on the Uptake of Quinidine and Procainamide in LS180 Cells
(A) 100 mM quinidine, (B) 100 mM procainamide. Open and hatched columns represent the uptake of drugs at pH 5.5 and 7.5, respectively. The cells were incubated with the radio-labeled drug for 5 min. Each column represents the meanϮS.E. for 6 measurements. * p<0.05; significantly different from pH 5.5. the initial (5-min) cellular uptake of procainamide was essentially Na ϩ -independent, but was significantly increased at pH 7.5 as compared with pH 5.5. In addition, the cellular uptake of procainamide was also inhibited by hydrophobic organic cations, but not by TEA and choline (Fig. 5B) . The rank order of the inhibitory effects of hydrophobic cationic drugs on the uptake of procainamide was imipramineϾquinidineϾ diphenhydramineϷpyrilamineϾprocainamide, which was con sistent with that on the uptake of quinidine (Figs. 5A, B) . These findings suggested that the cation transport system for procainamide in intestinal LS180 cells is similar/identical to that for quinidine.
DISCUSSION
The present study had two major findings. First, procainamide (but not quinidine) was transported by the cation transport systems in renal epithelial LLC-PK 1 cells. Second, both procainamide and quinidine were transported by another cation transport system in intestinal epithelial LS180 cells.
During the secretion of organic cations in the renal proximal tubules, cations are translocated across the basolateral membrane, and then are released across the luminal membrane.
12) The porcine kidney epithelial cell line LLC-PK 1 possesses the morphological structure and function similar to those of renal proximal tubular cells, and has been widely used to elucidate the transport properties of cationic drugs. 1, [13] [14] [15] [16] The membrane transport characteristics of TEA, a prototypical substrate of organic cation transport systems in the kidney, have been well evaluated using LLC-PK 1 cells. 1, 14, 17) TEA was transported directionally across LLC-PK 1 cell monolayers from the basolateral side to the apical side. 1, 14) The unidirectional transport of TEA was temperature-dependent and saturable, and was inhibited by organic cations, such as cimetidine and choline.
14) The basolateral uptake of TEA in LLC-PK 1 cells was dependent on the inside negative potential, and was decreased by lowering basolateral medium pH. 15, 18) On the other hand, the apical efflux of TEA in LLC-PK 1 cells was markedly stimulated by acidification of the apical medium. 14, 17) Recent studies have demonstrated that organic cation transporter 2 (OCT2) is expressed on the basolateral membrane of epithelial cells in renal proximal tubules, and that it translocates TEA in an electrogenic manner. 12, 19) In addition, multidrug and toxin extrusion 1 (MATE1) is localized to the brush-border membrane of renal proximal tubules, and is a TEA/proton antiporter. 12, 19) Takano et al. investigated the transport of procainamide in LLC-PK 1 cell monolayers. 16) They reported that the uptake of procainamide in LLC-PK 1 cells grown on plastic dishes was temperature-dependent and saturable, and was inhibited by cimetidine. The apical uptake of procainamide was greater at alkaline pH than acidic pH, and increased when intracellular pH was decreased, indicating the involvement of a H ϩ /procainamide antiport system in the apical membrane of LLC-PK 1 cells. In addition, the basolateral-to-apical transport of procainamide across LLC-PK 1 cell monolayers was greater than transport in the opposite direction, and was inhibited by cimetidine. 16) To our knowledge, the present study is the first report which provides apical and basolateral membrane transport clearance values of procainamide in renal epithelial LLC-PK 1 cells. The directional transport of procainamide across LLC-PK 1 cell monolayers was less than that of TEA (Figs. 1A, D) , and the CL B→C and CL C→A values of procainamide were smaller than those of TEA (Table 1 ). The findings suggested that procainamide is transported by cation-specific transport systems in renal LLC-PK 1 cells, but that the intrinsic activity and/or affinity are low as compared with TEA.
We previously evaluated the cellular uptake of 100 mM quinidine in intestinal epithelial Caco-2 cells, which are widely used as an experimental model to study the intestinal absorption of various drugs. 2, 7) The cellular uptake of quinidine in Caco-2 cells grown on plastic dishes was temperature-dependent, and markedly increased by alkalization of the apical medium at 37°C.
2) In addition, the uptake of quinidine was inhibited by hydrophobic organic cations, and the rank order of the inhibitory effects of hydrophobic cationic drugs was imipramineϾquinidineϾdiphenhydramine. 2, 7) In the present study, to confirm the involvement of the cation transport system in intestinal absorption of quinidine, we investigated the membrane transport mechanism of quinidine using another intestinal epithelial cell line, LS180. This cell line possesses characteristics of the small intestine (e.g., expression of microvillus), and has also been used as an in vitro model of the intestine. [8] [9] [10] [11] 20) The cellular uptake of quinidine in LS180 cells was temperature-and pH-dependent, and was inhibited by hydrophobic cationic drugs with the following rank order of inhibitory effect: imipramineϾquinidineϾ diphenhydramineϷpyrilamineϾprocainamide (Figs. 2-5 ). These findings indicated that the cation transport system is present not only in Caco-2 cells, but also in LS180 cells.
In the present study, we demonstrated that procainamide is transported by the TEA-insensitive cation transport system in human intestinal epithelial LS180 cells. Procainamide may be actively taken up by the cation transport system not only in the human intestine, but also in the rabbit intestine. Katsura et al. investigated the transport mechanism of procainamide using rabbit intestinal brush-border membrane vesicles.
21) The uptake of procainamide in the vesicles was stimulated by an outward H ϩ gradient, and the stimulation was reduced by the addition of carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone (FCCP), a protonophore. In addition, the initial uptake of procainamide was inhibited by tertiary amines, such as diphenhydramine and triethylamine, but not by TEA. They thought that the transport of procainamide at the intestinal brush-border membrane is mediated by the H ϩ /tertiary amine antiport system. 21 ) Further studies will be needed to identify the specific transport system for cationic drugs in the rabbit and/or human intestine.
In conclusion, cation transport systems in renal epithelial LLC-PK 1 cells transport procainamide, but not quinidine. In contrast, another cation transport system in intestinal epithelial LS180 cells takes up both quinidine and procainamide.
